Julie Cramer
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 2
- Colorectal Cancer Surgical Treatments 1
- Colorectal Cancer Treatments and Studies 1
- CAR-T cell therapy research 1
- Cancer Immunotherapy and Biomarkers 1
-
- Parkinson's Disease Mechanisms and Treatments 1
- Co-authors
- Steven A. Rosenberg (1 shared paper)Roxanne Payne (1 shared paper)Eric Tran (1 shared paper)Huayu Huang (1 shared paper)Bernard A. Fox (1 shared paper)Walter J. Urba (3 shared papers)Amy Leung (1 shared paper)Rom S. Leidner (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)New England Journal of Medicine (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesQatar
In The Last Decade
Julie Cramer
3 papers receiving 317 citations
Julie Cramer's Hit Papers
Peers
Comparison fields: 5 of 38
- Oncology 264
- Immunology 153
- Cancer Research 49
- Biotechnology 14
- Molecular Biology 97
Countries citing papers authored by Julie Cramer
This map shows the geographic impact of Julie Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Cramer more than expected).
Fields of papers citing papers by Julie Cramer
This network shows the impact of papers produced by Julie Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Cramer. The network helps show where Julie Cramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Julie Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer Hit paper breakdown → | 2022 | 319 |
| 2 | 2022 | 1 | |
| 3 | 2015 | 1 |
About Julie Cramer
Julie Cramer is a scholar working on Oncology, Neurology, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Cell Biology, having authored 3 papers that have together received 321 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (1 paper), Colorectal Cancer Treatments and Studies (1 paper), CAR-T cell therapy research (1 paper), Sirtuins and Resveratrol in Medicine (1 paper), Cancer Research and Treatments (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), Biotin and Related Studies (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (264 citations), Immunology (153 citations), Cancer Research (49 citations), Biotechnology (14 citations) and Molecular Biology (97 citations). Julie Cramer has collaborated with scholars based in United States and Qatar. Frequent co-authors include Steven A. Rosenberg, Roxanne Payne, Eric Tran, Huayu Huang, Bernard A. Fox, Walter J. Urba, Amy Leung, Rom S. Leidner, David E. Sprott and Chunhong Zheng. Their work appears in journals such as Journal of Clinical Oncology, New England Journal of Medicine and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.